Figure 1. Structure of the final multiepitope based vaccine.
At the C terminal, an adjuvant human B defesin3 has been added, and then it is linked with B cell epitopes using EAAAK linkers. B cell epitopes are linked with HTL with GPGPG linkers, and HTL are linked with CTL with AYY linkers. At N terminal, another adjuvant human B defensin-2 has been linked with six histidine sequences.